Global Veterinary Imaging Market Overview:
Significant growth in the population of small companion as well as large animals, rising demand for pet insurance along with increasing animal healthcare expenditure, and increasing number of veterinary practitioners are the major drivers for the growth of the veterinary imaging market. Other factors such as the launch of innovative products that offer rapid and accurate results such as portable imaging modalities and rising demand for animal-derived food products are also contributing to the growth of the this market.
- Growth in the Companion Animal Population
- Rising Demand for Pet Insurance
- Growing Number of Veterinary Practitioners & their Rising Income Levels in Developed Economies
- Growing Prevalence of Animal Diseases
- High Cost of Veterinary Imaging Instruments
- Untapped Emerging Markets
- Growing Animal Health Expenditure
- Lack of Animal Healthcare Awareness in Emerging Countries
- Shortage of Veterinary Practitioners in Developing Markets
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail a competitive advantage through combined collaborations.
Some of the key players profiled in the report are GE Healthcare (United States), Agfa-Gevaert N.V. (Belgium), Carestream Health, Inc. (United States), Esaote S.p.A (Italy), IDEXX Laboratories, Inc. (United States), Mindray Medical International Limited (China), Canon Inc. (Japan), Heska Corporation (United States), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Konica Minolta (Japan), Samsung Electronics Co. Ltd. (South Korea) and E.I. Medical Imaging (United States). Additionally, following companies can also be profiled that are part of our coverage like IMV imaging (United Kingdom), SEDECAL (Spain), Clarius Mobile Health (Canada), Shenzhen Ricso Technology Co., Ltd. (China), DRAMIŃSKI S.A. (Poland) and EPICA Animal Health (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Veterinary Imaging market by 2026. Considering Market by Animal , the sub-segment i.e. Small Companion Animals will boost the Veterinary Imaging market. Considering Market by End User, the sub-segment i.e. Veterinary Clinics and Diagnostic Centers will boost the Veterinary Imaging market. Considering Market by Therapeutic Area, the sub-segment i.e. Orthopedics and Traumatology will boost the Veterinary Imaging market.
Latest Market Insights:
In April 2020, Heska Corporation (US) acquired Scil Animal Care Company GmbH (Germany). This acquisition helped Heska expand its presence in the European veterinary imaging market.
In January 2020, IDEXX Laboratories (US) launched upgraded IDEXX Web PACS for veterinary applications
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Veterinary Imaging market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Veterinary Imaging market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Veterinary Imaging Provider, Technology Provider, Veterinary Imaging Manufacturers, Veterinary Imaging Distributors and Suppliers, Research and Development Institutes, Potential Investors, Industry Associations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.